CN104017016B - The preparation method of the intermediate of one class Entecavir, and intermediate - Google Patents
The preparation method of the intermediate of one class Entecavir, and intermediate Download PDFInfo
- Publication number
- CN104017016B CN104017016B CN201310062883.4A CN201310062883A CN104017016B CN 104017016 B CN104017016 B CN 104017016B CN 201310062883 A CN201310062883 A CN 201310062883A CN 104017016 B CN104017016 B CN 104017016B
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- acid
- substituent
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960000980 entecavir Drugs 0.000 title claims abstract description 25
- YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 85
- 238000006243 chemical reaction Methods 0.000 claims abstract description 80
- 239000002904 solvent Substances 0.000 claims abstract description 27
- 239000007848 Bronsted acid Substances 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 9
- 125000006239 protecting group Chemical group 0.000 claims abstract description 8
- 125000001424 substituent group Chemical group 0.000 claims description 80
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 51
- 239000003960 organic solvent Substances 0.000 claims description 51
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 27
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- -1 methoxyl group Chemical group 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical class CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 238000005822 methylenation reaction Methods 0.000 claims description 7
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 229910052701 rubidium Inorganic materials 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 4
- UBZYKBZMAMTNKW-UHFFFAOYSA-J titanium tetrabromide Chemical compound Br[Ti](Br)(Br)Br UBZYKBZMAMTNKW-UHFFFAOYSA-J 0.000 claims description 4
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 4
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 3
- 229910017604 nitric acid Inorganic materials 0.000 claims description 3
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims 1
- CCTHTLJWXPUNGT-UHFFFAOYSA-L nysted reagent Chemical compound C1CCOC1.Br[Zn]C[Zn]C[Zn]Br CCTHTLJWXPUNGT-UHFFFAOYSA-L 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 8
- 238000003912 environmental pollution Methods 0.000 abstract description 4
- 238000007086 side reaction Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 56
- 229910052799 carbon Inorganic materials 0.000 description 39
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 239000003513 alkali Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 20
- 238000003756 stirring Methods 0.000 description 19
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 15
- 238000007254 oxidation reaction Methods 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 13
- 229910052736 halogen Inorganic materials 0.000 description 13
- 150000002367 halogens Chemical class 0.000 description 13
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- HMDDXIMCDZRSNE-UHFFFAOYSA-N [C].[Si] Chemical group [C].[Si] HMDDXIMCDZRSNE-UHFFFAOYSA-N 0.000 description 12
- 150000001721 carbon Chemical group 0.000 description 12
- 238000007796 conventional method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
- 238000007792 addition Methods 0.000 description 11
- 239000003638 chemical reducing agent Substances 0.000 description 11
- 239000000376 reactant Substances 0.000 description 11
- 125000003545 alkoxy group Chemical group 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000006732 Fleming-Tamao oxidation reaction Methods 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 230000000977 initiatory effect Effects 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 125000005842 heteroatom Chemical group 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 239000004593 Epoxy Substances 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 6
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 6
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 6
- 230000001590 oxidative effect Effects 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 0 *C([C@](CC[C@@]1[n]2c(nc(NC(c3ccccc3)(c3ccccc3)c(cc3)ccc3O*)nc3OCc4ccccc4)*3nc2)C1=C)=O Chemical compound *C([C@](CC[C@@]1[n]2c(nc(NC(c3ccccc3)(c3ccccc3)c(cc3)ccc3O*)nc3OCc4ccccc4)*3nc2)C1=C)=O 0.000 description 5
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000010583 slow cooling Methods 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 238000007259 addition reaction Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000003682 fluorination reaction Methods 0.000 description 4
- 208000002672 hepatitis B Diseases 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000006317 isomerization reaction Methods 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 238000007142 ring opening reaction Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical group [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- OBTZDIRUQWFRFZ-UHFFFAOYSA-N 2-(5-methylfuran-2-yl)-n-(4-methylphenyl)quinoline-4-carboxamide Chemical compound O1C(C)=CC=C1C1=CC(C(=O)NC=2C=CC(C)=CC=2)=C(C=CC=C2)C2=N1 OBTZDIRUQWFRFZ-UHFFFAOYSA-N 0.000 description 3
- 150000005759 2-chloropyridine Chemical class 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- NUUNDIOOYFEMQN-UHFFFAOYSA-N cyclopenta-1,3-diene;sodium Chemical compound [Na].C1C=CC=C1 NUUNDIOOYFEMQN-UHFFFAOYSA-N 0.000 description 3
- FBCCMZVIWNDFMO-UHFFFAOYSA-N dichloroacetyl chloride Chemical compound ClC(Cl)C(Cl)=O FBCCMZVIWNDFMO-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 3
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 description 2
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- ZMCUDHNSHCRDBT-UHFFFAOYSA-M caesium bicarbonate Chemical compound [Cs+].OC([O-])=O ZMCUDHNSHCRDBT-UHFFFAOYSA-M 0.000 description 2
- 229910000025 caesium bicarbonate Inorganic materials 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical group [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- ZYMCBJWUWHHVRX-UHFFFAOYSA-N (4-nitrophenyl)-phenylmethanone Chemical class C1=CC([N+](=O)[O-])=CC=C1C(=O)C1=CC=CC=C1 ZYMCBJWUWHHVRX-UHFFFAOYSA-N 0.000 description 1
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 108090000656 Annexin A6 Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- SZTWIENARYFJMD-UHFFFAOYSA-N CC1S(C)CCCC1 Chemical compound CC1S(C)CCCC1 SZTWIENARYFJMD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 238000006646 Dess-Martin oxidation reaction Methods 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FCVHBUFELUXTLR-UHFFFAOYSA-N [Li].[AlH3] Chemical compound [Li].[AlH3] FCVHBUFELUXTLR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- VPCAAUUIFCAFRZ-UHFFFAOYSA-N butylalumane Chemical compound CCCC[AlH2] VPCAAUUIFCAFRZ-UHFFFAOYSA-N 0.000 description 1
- OHFQALRFLNKBNL-UHFFFAOYSA-N carbonic acid;ethanol Chemical compound CCO.OC(O)=O OHFQALRFLNKBNL-UHFFFAOYSA-N 0.000 description 1
- QGNFYIMZILGXLE-UHFFFAOYSA-M cesium periodate Chemical compound [Cs+].[O-]I(=O)(=O)=O QGNFYIMZILGXLE-UHFFFAOYSA-M 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- KWYZNESIGBQHJK-UHFFFAOYSA-N chloro-dimethyl-phenylsilane Chemical compound C[Si](C)(Cl)C1=CC=CC=C1 KWYZNESIGBQHJK-UHFFFAOYSA-N 0.000 description 1
- OJZNZOXALZKPEA-UHFFFAOYSA-N chloro-methyl-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C)C1=CC=CC=C1 OJZNZOXALZKPEA-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960001627 lamivudine Drugs 0.000 description 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical class O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 150000002642 lithium compounds Chemical class 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005648 named reaction Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N penta-1,3-diene Chemical compound CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane group Chemical group C12C(CCC(C1(C)C)C2)C XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- FJVZDOGVDJCCCR-UHFFFAOYSA-M potassium periodate Chemical compound [K+].[O-]I(=O)(=O)=O FJVZDOGVDJCCCR-UHFFFAOYSA-M 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Chemical class [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention discloses the preparation method of the intermediate of a class Entecavir, and intermediate.The preparation method of the intermediate of the Entecavir as shown in formula IV or IV ' is comprised the steps of:In solvent, in the presence of Bronsted acid, compound V is carried out into the as follows reaction for sloughing amino protecting group and hydroxyl protecting group, you can.The preparation method raw material of the present invention is cheap and easy to get, and reaction condition is gentle, side reaction is few, high income, environmental pollution are little, and intermediate is easy to purifies and separates, is suitable to industrialized production.
Description
Technical field
The present invention is specifically related to the preparation method of the intermediate of a class Entecavir, and intermediate.
Background technology
Nucleotide analog is used as an important chemical type, the extensive pass for having obtained inside pharmaceutical chemistry
Note.Relative research has created large quantities of significant medicines, especially in antiviral field.It is a great deal of
Anti-AIDS and anti-hbv drug both be from the further investigation in the field.
There are 3.5 hundred million~4.0 hundred million hepatitis type B virus (HBV) the infecteds in the whole world, wherein there is nearly 1,000,000 patient to die from every year
Cirrhosis and liver cancer that HBV infection causes.There are more than 1.2 hundred million HBV infection persons in China, account for more than the 1/3 of the world total, occupy generation
The 1st, boundary, chronic hepatitis B (hepatitis B) patient 30,000,000, and also this numeral is just in rising trend at present.Chronic second
Hepatovirus infection does not also have the method that can cure completely till now, and patient needs long-term or lifelong(Majority of case
Under)Carry out HIV suppression.The clinical guidelines recommended therapy course for the treatment of is at least 1 year.Nucleoside medicine in the medicine of current hepatitis B
Occupation rate of market cross 80%.In nucleoside medicine, Entecavir relies on its obvious curative effect and good anti-drug resistance, from
Since 2007, having substituted Lamivudine becomes the anti-hepatic-B virus medicine of a line.Entecavir is by U.S.'s Bristol Myers Squibb
Company develops, and on March 29th, 2005, approval was listed U.S. FDA.State food drug surveilance is obtained on November 15th, 2005
Management board SFDA ratifies Discussion on Chinese Listed.Drug patent expired in 2008.Because its synthesis difficulty is huge, its active component
(API)Price is high at present, and manufacturer is few.
The bulk drug of Entecavir causes extensive concern in scientific circles because its huge synthesis challenge.With regard to grace
Therefore synthetic methodology research for card Wei obtained deep development.Wherein more representational synthetic route is in the institute such as Shen Guobing
Write《Entecavir route is illustrated》(749-752 page of 10 phase of volume 38 of Chinese Journal of Pharmaceuticals 2007)And the paper is drawn
There is detailed review paper in document.Other related documents such as, but not limited to CN1861602A,
CN101050216A、CN101182322A、CN101210015A、CN101235034A、CN101245067A、
CN101531660A、CN101723945A、CN101756890A、CN101759698A、CN101781301A、
CN101805339A、CN101830856A、CN101838207A、CN101838270A、CN101863842A、
CN101891741A、CN101906113A、CN102002023A、CN102225938A、CN102229608A、
DE102009060194A1、EP2433941A1、SG171963A1、TW201118097A、US2006106216A1、
Draw inside US2010286089A1, WO2011102806A1, WO2011150513A1, WO2012006964A1 and these documents
Other documents.
The larger problem that current most synthetic routes are present, such as equivalent use Dess-Martin reagents, two pinanes
The raw material costly such as alkene borine and reagent, experiment condition are harsh, and separating step is complicated, needs silica gel chromatograph post separation contour
The means of purification of cost, is not suitable for big production.
A wherein comparatively practical production line(WO2005118585)It is as follows.There is the route reaction to receive
The features such as rate is high, working condition is gentle, purification step is simple, is adapted to amplify production.But also there is its corresponding defect, such as one
A little reagents such as phenyldimethylchlorosilane production difficulty cause high price, high toxicity reagent such as boron trifluoride use,
And the intermediate of the overwhelming majority is all purification difficult caused by oily liquids institute in process of production.
The synthetic route similar to which in document CN101050216A has been made to be discussed in detail, and has larger changing on cost
Enter, the relatively low diphenyl methyl chloro silane of price is employed as initiation material.But it is because that two phenyl ring are connected with silicon atom
Caused by huge steric effect cause still avoid using the borontrifluoride of high poison high pollution during the last deprotection of the route
Boron.
The content of the invention
The technical problem to be solved is to overcome the synthesising method reacting condition of existing Entecavir severe
Carve, yield is high, environmental pollution is larger and expensive starting materials caused by the defect such as production cost is huge, and provide a class grace
For the preparation method of the intermediate of card Wei, and intermediate.The preparation method raw material of the present invention is cheap and easy to get, reaction condition temperature
Little with, few side reaction, high income, environmental pollution, intermediate is easy to purifies and separates, is suitable to industrialized production.
Present invention firstly provides the system of a kind of intermediate of Entecavir as shown in formula IV or its dynamic isomer IV '
Preparation Method, which comprises the steps of:In solvent, in the presence of Bronsted acid, compound V is carried out as follows sloughing amino
The reaction of protection group and hydroxyl protecting group, you can;
Wherein, RaFor C1~C4Straight chained alkyl(It is preferred that methyl);RbRepresent phenyl ring on one or more selected from halogen atom,
The substituent or H of methoxyl group or methyl;RcFor methyl;R2The substituent being as follows:
Wherein, R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described replacement
Pyridine radicals in substituent be C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, per the number of class substituent
For one or more;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3In alkoxyl
One or more, the number per class substituent is one or more;
Y is 3 ~ 9 carbon for connecting or being not connected to other substituents, so as to form substituted or unsubstituted 4 ~ 10 yuan with Si
Saturation or undersaturated silicon-carbon ring;Or, Y is to connect or be not connected to other substituents, and sum is the carbon atom of 3 ~ 9 and miscellaneous
Atom, so as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated carbon sila ring, the hetero atom is O, S
Or N, heteroatomic number is 1 ~ 3;Substituent in described replacement is C1~C3Alkyl;Described silicon-carbon ring or carbon sila ring
For a ring or and two rings together(For example
Described R2Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
Described R21Preferably following arbitrary substituent:
In the present invention, the method and condition of the described reaction for sloughing amino protecting group and hydroxyl protecting group can be ability
The conventional method and condition of this two classes reaction of domain, following conditions specifically preferred according to the invention:Described preferred solvents for organic molten
Agent, water or their mixture, wherein described organic solvent is preferably dichloromethane, methyl alcohol, ethanol, isopropanol, tertiary fourth
One or more in alcohol, tetrahydrofuran, acetonitrile, DMF and dimethyl sulfoxide (DMSO).The volume mass ratio of the solvent and compound V
Preferably 2ml/g ~ 20ml/g, more preferably 5ml/g ~ 15ml/g.Described Bronsted acid be preferably hydrochloric acid, sulfuric acid, nitric acid,
One or more in trifluoroacetic acid and methanesulfonic acid.Bronsted acid is preferably 0.1 ~ 100 with the mol ratio of compound V, more preferably
For 1 ~ 20.Till the time of described reaction can be no longer carried out by detection reaction, generally 0.5 ~ 36 hour.Described reaction
Temperature be preferably 0 ~ 100 DEG C, more preferably 20 ~ 80 DEG C.The described reaction for sloughing amino protecting group and hydroxyl protecting group
Can carry out simultaneously.
In the present invention, above-claimed cpd V can be prepared by following methods:
Under inert gas shielding, in organic solvent, in the presence of titanium tetrabromide or titanium tetrachloride, compound VI and will receive
Si Te(Nysted)Reagent carries out methylenation, you can;
Wherein, Ra、Rb、RcAnd R2Definition be the same as those described above.
Wherein, described Na Site(Nysted)The reagent that reagent is known in the art, its structure are as follows:
In the present invention, the method and condition of described methylenation can be the conventional method of this kind of reaction in this area
And condition, following conditions specifically preferred according to the invention:Described organic solvent be preferably tetrahydrofuran, 2- methyltetrahydrofurans,
One or more in ether and t-butyl methyl ether.The volume mass of described organic solvent and compound VI than preferably 2 ~
50, more preferably 5 ~ 20.Described inert gas is preferably argon gas.Described Na Site(Nysted)Reagent and compound VI
Mol ratio be preferably 0.5 ~ 10, more preferably 1 ~ 5.The mol ratio of described titanium tetrabromide or titanium tetrachloride and compound VI
Preferably 0.1 ~ 10, more preferably 1 ~ 5.The time of described methylenation can be by detecting that behavior is no longer entered in reaction
Only, generally 0.5 ~ 24 hour, more preferably 1 ~ 12 hour.The temperature of described methylenation is preferably -78 ~ 50
DEG C, more preferably -45 ~ 25 DEG C.
Present invention also offers the midbody compound of the Entecavir as shown in Formula V or VI, or as shown in formula IV
The midbody compound of Entecavir or its dynamic isomer IV ':
Wherein, Ra、Rb、RcAnd R2Definition be the same as those described above.
In the present invention, Entecavir or its dynamic isomer can be prepared by following methods:
A kind of preparation method of Entecavir or its dynamic isomer I ' shown in formula I, which comprises the steps of:It is organic
In solvent, in the presence of reducing agent, compound II is carried out into the as follows reaction that ester is reduced to alcohol, you can;
Wherein, RaFor C1~C4Straight chained alkyl(It is preferred that methyl);Described reducing agent is diisobutyl aluminium hydride, aluminum hydride
Lithium, red aluminum(It is double(2- methoxy ethoxies)Sodium aluminum hydride)Or sodium borohydride, when reducing agent is sodium borohydride, the reaction
Carry out in the presence of lithium chloride and/or lithium bromide.
In the present invention, the species of described organic solvent is not particularly limited, and does not affect to react the such reduction reaction for carrying out
Conventional solvent is applicable, such as in dichloromethane, toluene, 1,2- dichloroethanes, tetrahydrofuran and 2- methyltetrahydrofurans
One or more.The volume mass of described organic solvent and compound II or II ' than preferably 3 ~ 20ml/g, more preferably
For 5 ~ 12ml/g.
In the present invention, the consumption of reducing agent can be the conventional amount used of the such reduction reaction in this area, for example, compound II
Or 1 ~ 5 times of II ', following ranges specifically preferred according to the invention:The mol ratio of described reducing agent and compound II or II ' is preferably
For 1.1 ~ 3.When reducing agent is sodium borohydride, the reaction is carried out in the presence of lithium chloride and/or lithium bromide, described chlorine
The mol ratio for changing lithium and/or lithium bromide with compound II or II ' is preferably 0.1 ~ 2.
In the present invention, the temperature of the above-mentioned reaction that ester is reduced to alcohol is preferably -78 ~ 100 DEG C, more preferably -20 ~
40℃.The time of the above-mentioned reaction that ester is reduced to alcohol can be by, till detecting that reaction is no longer carried out, generally 0.5 ~ 12 is little
When.
In the present invention, after the Entecavir or its dynamic isomer I ' being obtained by above-mentioned preparation method shown in formula I,
, can be carried out in Formulas I or I ' compound structures at 60 ~ 100 DEG C after for example adding water by the conventional post processing mode in this area
The reaction of one hydrone, filters(Such as filtered with diatomite), by filtrate crystallisation by cooling, you can obtain the entecavir with a crystallization water
Wei compound or its tautomerism compound, it is as follows:
In the present invention, above-claimed cpd II or its dynamic isomer II ' can be prepared by following methods:
In solvent, compound III or its dynamic isomer III ' are carried out into Tamao-Fleming oxidation reactions, you can;
Wherein, RaIt is as defined above described;R1ForY is 3 ~ 9 carbon for connecting or being not connected to other substituents,
So as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated silicon-carbon ring;Or, Y is for connection or is not connected to which
His substituent, sum is carbon atom and the hetero atom of 3 ~ 9, so as to substituted or unsubstituted 4 ~ 10 yuan of saturation is formed with Si
Or undersaturated carbon sila ring, the hetero atom is O, S or N, and heteroatomic number is 1 ~ 3;Replacement in described replacement
Base is C1~C3Alkyl;Described silicon-carbon ring or carbon sila ring are a ring or and two rings together(For exampleOr
Described R1Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
In the present invention, described Tamao-Fleming oxidation reactions are the classical name reactions of this area, said method and
Condition can be the conventional method and condition of the such Tamao-Fleming oxidation reactions in this area, for example, may be referred to document
(Fleming,I;Barbero,A;Walter,D;Chem Rev, 1997,97,2063-2192) in method carry out.
For above-mentioned Tamao-Fleming oxidation reactions, method specifically preferred according to the invention and condition:
Described Tamao-Fleming oxidation reactions are preferably comprised the steps of:
In solvent, in the presence of alkali and fluorination reagent, compound III or III ' and oxidant are carried out into Tamao-
Fleming oxidation reactions.
Wherein, described preferred solvents in water, methyl alcohol, tetrahydrofuran, ethanol and DMF
Plant or several.The volume mass of solvent and compound III or III ' is than preferably 1 ~ 300ml/g, more preferably 3 ~ 100ml/
g.Described alkali is preferably triethylamine, diisopropylethylamine (Hunig base), saleratus, sodium acid carbonate and caesium bicarbonate
In one or several.The mol ratio of described alkali and compound III or III ' is preferably 0.5 ~ 30, more preferably 0.8 ~
15.Described oxidant be preferably hydrogen peroxide, Peracetic acid, tert-Butanol peroxide, metachloroperbenzoic acid, chlorine, bromine,
One or more in iodine, N- dichloro-succinic acids Asia acid amides, N- bromosuccinic acids Asia acid amides and N- iodos succinic acid Asia acid amides.Institute
The concentration of the hydrogen peroxide stated is preferably mass percent 1% to 60%.Described oxidant and compound III or III ' mole
Than being preferably 0.8 ~ 30, more preferably 1 ~ 20.Described fluorination reagent is preferably sodium fluoride, cesium fluoride, potassium fluoride, fluorination
One or more in hydrogen and boron trifluoride.Fluorination reagent is preferably 0.8 ~ 30 with the mol ratio of compound III or III ', more
It is good for 1 ~ 10.The time of described Tamao-Fleming oxidation reactions can be by till detecting that reaction is no longer carried out.Described
The temperature of Tamao-Fleming oxidation reactions is preferably -20 DEG C ~ 120 DEG C(More preferably 0 ~ 80 DEG C).
In the present invention, above-claimed cpd III or III ' are prepared by following methods:
In solvent, in the presence of Bronsted acid, compound IV or its dynamic isomer IV ' are hydrolyzed reaction, will
R2In R21Substituent replaces with hydroxyl;
R1And RaDefinition be the same as those described above, R2For R1In hydroxyl replace with R21Substituent, i.e.,
Except R21Outward, the same R of each group definition1Described in;
R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described substituted pyridine
Substituent in base is C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, the number per class substituent are one
Or it is multiple;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3One kind in alkoxyl or
Various, the number per class substituent is one or more.
Preferably, described R21For following arbitrary substituent:
Prepare in the method for above-claimed cpd III or its dynamic isomer III ', described solvent can be to common are machine
Solvent or water, or their mixture, described organic solvent can be dichloromethane, 1,2- dichloroethanes, tetrahydrofuran, 2-
One or more in methyltetrahydrofuran, acetonitrile, methyl alcohol, ethanol, isopropanol, toluene and t-butyl methyl ether.The solvent with
The volume mass of compound IV or IV ' is than preferably 1 ~ 20ml/g.Described Bronsted acid can for hydrochloric acid, sulfuric acid, trifluoroacetic acid,
One or more in nitric acid, methanesulfonic acid and TFMS.Bronsted acid with the mol ratio of compound IV or IV ' is preferably
0.1~20.Till the time of described reaction can be no longer carried out by detection reaction, generally 0.5 ~ 24 hour.Described reaction
Temperature be preferably -20 ~ 80 DEG C, with acid species change.
In the present invention, the intermediate of the described Entecavir as shown in Formula IV can be prepared by following methods:
In the present invention, the intermediate of the Entecavir as shown in Formula IV can be obtained by following methods:It is non-proton organic molten
In agent, in the presence of alkali, compound VII and compound VI ' are carried out into the reaction of upper amino protecting group as follows, i.e.,
Can;
Wherein, X is halogen(Such as chlorine, bromine or iodine), RaFor C1~C4Straight chained alkyl(It is preferred that methyl);RbRepresent on phenyl ring
One or more substituents or H selected from halogen atom, methoxyl group or methyl;RcFor methyl;R2The substituent being as follows:
Wherein, R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described replacement
Pyridine radicals in substituent be C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, per the number of class substituent
For one or more;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3In alkoxyl
One or more, the number per class substituent is one or more;
Y is 3 ~ 9 carbon for connecting or being not connected to other substituents, so as to form substituted or unsubstituted 4 ~ 10 yuan with Si
Saturation or undersaturated silicon-carbon ring;Or, Y is to connect or be not connected to other substituents, and sum is the carbon atom of 3 ~ 9 and miscellaneous
Atom, so as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated carbon sila ring, the hetero atom is O, S
Or N, heteroatomic number is 1 ~ 3;Substituent in described replacement is C1~C3Alkyl;Described silicon-carbon ring or carbon sila ring
For a ring or and two rings together(For exampleOr
Described R2Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
Described R21Preferably following arbitrary substituent:
In the present invention, the method and condition that described upper amino protecting group reacts can be the normal of this two classes reaction of this area
Rule method and condition, following conditions specifically preferred according to the invention:Described aprotic organic solvent can be the conventional non-matter in this area
Sub- organic solvent, such as DMF, dimethyl sulfoxide (DMSO), acetonitrile, tetrahydrofuran, 2- methyltetrahydrofurans and N- methyl
One or more in pyrrolidones.The volume mass of described organic solvent and compound VII than preferably 1ml/g ~
100ml/g, preferable 3ml/g ~ 20ml/g.Described alkali be preferably DMAP, triethylamine, diisopropylethylamine,
One or more in potassium carbonate, sodium carbonate and cesium carbonate.The mol ratio of described alkali and compound VII is preferably 0.5 ~
10, preferably 1 ~ 5.The mol ratio of described compound VI ' and compound VII is preferably 0.5 ~ 10, more preferably 1 ~ 3.
Till the time of the reaction of described upper amino protecting group can be no longer carried out by detection reaction, generally 0.5 ~ 72 hour, more
It is good for 1 ~ 24.The temperature of the reaction of described upper amino protecting group is preferably 0 ~ 150 DEG C, more preferably 25 ~ 80 DEG C.
In the present invention, above-claimed cpd VII can be prepared by following methods:
In aprotic organic solvent, compound VIII and oxidant are carried out into oxidation reaction as follows, you can;
Wherein, Ra、RbAnd R2Definition be the same as those described above.
In the present invention, the method and condition of above-mentioned oxidation reaction can be the conventional method and bar of this kind of reaction in this area
Part, following conditions specifically preferred according to the invention:Described aprotic organic solvent be preferably dichloromethane, n-hexane, toluene and
One or more in ethyl acetate.The volume mass of described aprotic organic solvent and compound VIII than preferably 1 ~
100, preferably 3 ~ 20.Described oxidant is preferably sodium metaperiodate, potassium metaperiodate, cesium periodate, sodium chlorate, chloric acid
One or more in potassium, sodium hypochlorite and postassium hypochlorite.Described oxidant with the mol ratio of compound VIII is preferably
0.5 ~ 10, more preferably 1 ~ 3.Described oxidation reaction is carried out preferably in the presence of alkali, and described alkali is preferably carbonic acid
Hydrogen potassium, one or more in sodium acid carbonate and caesium bicarbonate.Described alkali is preferably 0.5 with the mol ratio of compound VIII
~ 10, preferably 1 ~ 5.The time of described oxidation reaction can be by, till detecting that reaction is no longer carried out, generally 0.5 ~ 72 is little
When, more preferably 1 ~ 24 hour.The temperature of described oxidation reaction is preferably -20 ~ 80 DEG C, more preferably 0 ~ 60 DEG C.
In the present invention, the intermediate of the Entecavir as shown in Formula VIII can be obtained by following methods:It is non-proton organic
In solvent, in the presence of alkali, compound IX and VIII ' are carried out into ring-opening reaction as follows, you can;
Wherein, RaFor C1~C4Straight chained alkyl(It is preferred that methyl);RbOne or more on phenyl ring are represented selected from halogen atom,
The substituent or H of methoxyl group or methyl;R2The substituent being as follows:
Wherein, R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described replacement
Pyridine radicals in substituent be C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, per the number of class substituent
Mesh is one or more;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3Alkoxyl
In one or more, the number per class substituent is one or more;
Y is 3 ~ 9 carbon for connecting or being not connected to other substituents, so as to form substituted or unsubstituted 4 ~ 10 yuan with Si
Saturation or undersaturated silicon-carbon ring;Or, Y is to connect or be not connected to other substituents, and sum is the carbon atom of 3 ~ 9 and miscellaneous
Atom, so as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated carbon sila ring, the hetero atom is O, S
Or N, heteroatomic number is 1 ~ 3;Substituent in described replacement is C1~C3Alkyl;Described silicon-carbon ring or carbon sila
Ring is a ring or and two rings together(For exampleOr
Described R2Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
Described R21Preferably following arbitrary substituent:
Wherein, the method and condition of described ring-opening reaction can be the conventional method and condition of this kind of reaction in this area,
Following conditions specifically preferred according to the invention:Described aprotic organic solvent can be the conventional aprotic organic solvent in this area, such as
In N,N-dimethylformamide, dimethyl sulfoxide (DMSO), acetonitrile, tetrahydrofuran, 1-METHYLPYRROLIDONE and 2- methyltetrahydrofurans
One or more.The volume mass of described organic solvent and compound IX than preferably 1ml/g ~ 100ml/g, preferably
3ml/g~20ml/g.Described alkali is preferably lithium hydroxide and/or lithium hydride.The mol ratio of described alkali and compound IX compared with
It is good for 0.01 ~ 10, more preferably 0.05 ~ 5.The mol ratio of described compound VIII ' and compound IX is preferably 0.5 ~
10, more preferably 1 ~ 3.The time of described ring-opening reaction can be by, till detecting that reaction is no longer carried out, generally 0.5 ~ 72 is little
When, more preferably 3 ~ 48 hours.The temperature of described ring-opening reaction is preferably 0 ~ 150 DEG C, more preferably 25 ~ 120 DEG C.
In the present invention, above-claimed cpd IX can be prepared by following methods:
In organic solvent, compounds X is carried out into Sharpless chiral epoxy reactions, you can;
Wherein, RaAnd R2Definition be the same as those described above.
Wherein, the method and condition of described Sharpless chiral epoxies reaction can be the normal of this kind of reaction in this area
Rule method and condition, such as can refer to document (Pfenninger, A.Synthesis1986,89)In method and condition carry out, can
For following methods:In organic solvent, in the presence of tetraisopropoxy titanium and chiral ligand, compounds X and peroxide are entered
Row Sharpless chiral epoxies react, you can.
Following conditions specifically preferred according to the invention:Described organic solvent can be dichloromethane and/or 1,2- dichloroethanes.Institute
The volume mass of the organic solvent stated and compounds X is than preferably 1ml/g ~ 100ml/g, more preferably 3ml/g ~ 20ml/g.
Described chiral ligand is preferably(2S, 3S)- ethyl tartrate or(2S, 3S)- tartaric acid diisopropyl ester.Hand-type part with
The mol ratio of compounds X is preferably 0.0001 ~ 1, more preferably 0.001 ~ 0.3.Tetraisopropoxy titanium and compounds X mole
Than being preferably 0.0001 ~ 1, more preferably 0.001 ~ 0.3.Described peroxide is preferably tert-Butanol peroxide, peroxidating
One or more in hydrogen, Peracetic acid and metachloroperbenzoic acid.Described peroxide is preferable with the mol ratio of compounds X
For 0.5 ~ 10, more preferably 1 ~ 5.Till the time of described chiral epoxy reaction can be no longer carried out by detection reaction,
Generally 0.25 ~ 12 hour, more preferably 0.5 ~ 8 hour.The temperature of described chiral epoxy reaction is preferably -78 ~ 25
DEG C, more preferably -60 ~ 0 DEG C.
In the present invention, the intermediate of Entecavir represented by a formula X can be obtained by following methods:
Step(1):In organic solvent, by compounds X I and(1R,2R)- 2- amino -1-(4- nitrobenzophenones)Propane -1,3-
Glycol is reacted;
Step(2):In organic solvent, in the presence of the concentrated sulfuric acid, by step(1)The material for obtaining and RaOH is esterified
Reaction, you can;
Wherein, RaFor C1~C4Straight chained alkyl(It is preferred that methyl);
R2The substituent being as follows:
Wherein, R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described replacement
Pyridine radicals in substituent be C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, per the number of class substituent
Mesh is one or more;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3Alkoxyl
In one or more, the number per class substituent is one or more;
Y is 3 ~ 9 carbon for connecting or being not connected to other substituents, so as to form substituted or unsubstituted 4 ~ 10 yuan with Si
Saturation or undersaturated silicon-carbon ring;Or, Y is to connect or be not connected to other substituents, and sum is the carbon atom of 3 ~ 9 and miscellaneous
Atom, so as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated carbon sila ring, the hetero atom is O, S
Or N, heteroatomic number is 1 ~ 3;Substituent in described replacement is C1~C3Alkyl;Described silicon-carbon ring or carbon sila
Ring is a ring or and two rings together(For exampleOr
Described R2Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
Described R21Preferably following arbitrary substituent:
Step(1)In, the method and condition of described reaction can be the conventional method and condition of this kind of reaction in this area,
Following conditions specifically preferred according to the invention:Described organic solvent can be isopropanol, methyl alcohol, ethanol, water, N, N- dimethyl formyls
One or more in amine, dimethyl sulfoxide (DMSO), acetonitrile, tetrahydrofuran, 2- methyltetrahydrofurans and 1-METHYLPYRROLIDONE.It is described
Organic solvent and compounds X I volume mass than preferably 1ml/g ~ 100ml/g, more preferably 3ml/g ~ 20ml/g.Institute
State(1R,2R)- 2- amino -1-(4- nitrobenzophenones)Propane -1, the mol ratio of 3- glycol and compounds X I is preferably 0.25 ~
10, more preferably 0.4 ~ 3.The time of described reaction can be by, till detecting that reaction is no longer carried out, generally 0.25 ~ 72 is little
When, more preferably 0.5 ~ 24 hour.The temperature of described reaction is preferably 0 ~ 150 DEG C, more preferably 25 ~ 80 DEG C.
Step(2)In, the method and condition of described esterification can be the conventional method of this kind of reaction in this area and
Condition, following conditions specifically preferred according to the invention:Described organic solvent can be C1~C4Alkylol.Described organic solvent and chemical combination
The volume mass of thing XI is than preferably 1ml/g ~ 100ml/g, more preferably 3ml/g ~ 20ml/g.The quality of the described concentrated sulfuric acid
Percentage can be 60% ~ 98%(Such as 98%wt).The described concentrated sulfuric acid is preferably 0.01 ~ 100 with the mol ratio of compounds X I, more
It is good for 0.05 ~ 30.Till the time of described reaction can be no longer carried out by detection reaction, generally 0.5 ~ 72 hour, more
It is good for 1 ~ 48 hour.The temperature of described reaction is preferably -20 ~ 100 DEG C, more preferably -10 ~ 60 DEG C.
In the present invention, above-claimed cpd XI can be prepared by following methods:
In solvent, compounds X II is carried out into the reaction that carbonyl reduction is hydroxyl with reducing agent, you can;
Wherein, R2It is as defined above described.
Wherein, described carbonyl reduction can be the routine of this kind of reaction in this area for the method and condition of the reaction of hydroxyl
Method and condition, following conditions specifically preferred according to the invention:Described preferred solvents for alcohol organic solvent and/or water;Or
One or more in toluene, dichloromethane and tetrahydrofuran.The volume mass of solvent and compounds X II is than preferably 1ml/
G ~ 100ml/g, more preferably 3ml/g ~ 20ml/g.When solvent is alcohol organic solvent and/or water, described reducing agent can be
LiBH4、CsBH4、KBH4And NaBH4In one or more, the mol ratio of reducing agent and compounds X II can be 0.5 ~ 10, more preferably
For 1 ~ 3, described alcohol organic solvent can be one or more in isopropanol, methyl alcohol, ethanol, the tert-butyl alcohol and n-butanol.
When solvent is one or more in toluene, dichloromethane and tetrahydrofuran, described reducing agent can be lithium aluminium hydride reduction, two different
Butyl aluminum hydride or red aluminum(Double (2- methoxy ethoxies) sodium aluminum hydrides)), reducing agent with the mol ratio of compounds X II can be
0.5 ~ 10, more preferably 1 ~ 3.Described carbonyl reduction can be by detecting that behavior is no longer entered in reaction for the time of the reaction of hydroxyl
Only, generally 0.25 ~ 12 hour, more preferably 0.5 ~ 10 hour.Described carbonyl reduction is preferable for the temperature of the reaction of hydroxyl
For -78 ~ 120 DEG C, more preferably -60 ~ 60 DEG C.
In the present invention, the intermediate of the Entecavir as shown in Formula X II can be obtained by following methods:
In solvent, in the presence of alkali, compounds X III is carried out into isomerization reaction as follows, you can;
R2The substituent being as follows:
Wherein, R21For substituted or unsubstituted pyridine radicals or substituted or unsubstituted C6~C10Aryl, described replacement
Pyridine radicals in substituent be C1~C3Alkyl, halogen and C1~C3One or more in alkoxyl, per the number of class substituent
Mesh is one or more;Described substituted C6~C10Substituent in aryl is C1~C3Alkyl, halogen and C1~C3In alkoxyl
One or more, the number per class substituent is one or more;
Y is 3 ~ 9 carbon for connecting or being not connected to other substituents, so as to form substituted or unsubstituted 4 ~ 10 yuan with Si
Saturation or undersaturated silicon-carbon ring;Or, Y is to connect or be not connected to other substituents, and sum is the carbon atom of 3 ~ 9 and miscellaneous
Atom, so as to the saturation that substituted or unsubstituted 4 ~ 10 yuan are formed with Si or undersaturated carbon sila ring, the hetero atom is O, S
Or N, heteroatomic number is 1 ~ 3;Substituent in described replacement is C1~C3Alkyl;Described silicon-carbon ring or carbon sila
Ring is a ring or and two rings together(For exampleOr
Described R2Preferably following arbitrary substituent:
In substituent IVa, n be 0 ~ 2, p be 0 ~ 2, q be independently carbon, oxygen or nitrogen for 1 ~ 2, X and Y, R4For C1~C3Alkyl,
And R4For one or more substituents;When n is 0, X is carbon, and when p is 0, Y is carbon.
The more preferably following arbitrary substituents of substituent IVa:
Described R21Preferably following arbitrary substituent:
Wherein, the method and condition of described isomerization reaction can be the conventional method and bar of this kind of reaction in this area
Part, following conditions specifically preferred according to the invention:Described solvent can be isopropanol, methyl alcohol, ethanol, the tert-butyl alcohol, n-butanol, N, N- bis-
One kind in NMF, dimethyl sulfoxide (DMSO), acetonitrile, tetrahydrofuran, 2- methyltetrahydrofurans, 1-METHYLPYRROLIDONE and water
Or it is various.The volume mass of described solvent and compounds X III than preferably 1ml/g ~ 100ml/g, more preferably 3ml/g ~
20ml/g.Described alkali can be triethylamine, diisopropylethylamine, 11 carbon -7- alkene of 1,8- diazabicylos [5.4.0], carbonic acid
One or more in sodium, potassium carbonate, cesium carbonate, lithium carbonate, potassium hydroxide, lithium hydroxide, NaOH and cesium hydroxide.Institute
The alkali stated can be 0.5 ~ 10, more preferably 1 ~ 3 with the mol ratio of compounds X III.The time of described isomerization reaction can pass through
Till detection reaction is no longer carried out, generally 0.25 ~ 72 hour, more preferably 0.5 ~ 12 hour.Described isomerization reaction
Temperature is preferably -50 ~ 100 DEG C, more preferably -10 ~ 80 DEG C.
In the present invention, above-claimed cpd XIII is prepared by following methods:
In the mixed solution of organic solvent and water, in the presence of alkali, compounds X IV is carried out into hydrolysis as follows anti-
Should, you can;
Wherein, R2It is as defined above described.
Wherein, the method and condition of described hydrolysis can be the conventional method and condition of this kind of reaction in this area,
Following conditions specifically preferred according to the invention:Described organic solvent can be isopropanol, methyl alcohol, ethanol, the tert-butyl alcohol, n-butanol, N, N-
One or more in dimethylformamide, dimethyl sulfoxide (DMSO), acetonitrile, tetrahydrofuran and 1-METHYLPYRROLIDONE.Described has
The volume mass of machine solvent and compounds X IV is than preferably 0.5ml/g ~ 100ml/g, more preferably 1ml/g ~ 20ml/g.Institute
The volume mass of the water stated and compounds X IV is than preferably 0.25ml/g ~ 100ml/g, more preferably 0.5ml/g ~ 20ml/g.
Described alkali can be triethylamine, diisopropylethylamine, 11 carbon -7- alkene of 1,8- diazabicylos [5.4.0], sodium carbonate, carbonic acid
One or more in potassium, cesium carbonate, lithium carbonate, potassium hydroxide, lithium hydroxide, NaOH and cesium hydroxide.Described alkali
Mol ratio with compounds X IV is preferably 0.5 ~ 100, more preferably 1 ~ 50.The time of described hydrolysis can be by inspection
Till survey reaction is no longer carried out, generally 0.25 ~ 72 hour, more preferably 0.5 ~ 12 hour.The temperature of described hydrolysis
Preferably -10 ~ 150 DEG C, more preferably 0 ~ 120 DEG C.
In the present invention, above-claimed cpd XIV can be prepared by following methods:
In organic solvent, in the presence of alkali, compounds X V and dichloroacetyl chloride are carried out into addition reaction as follows,
;
Wherein, R2It is as defined above described.
Wherein, the method and condition of described addition reaction can be the conventional method and condition of this kind of reaction in this area,
Following conditions specifically preferred according to the invention:
Described organic solvent is preferably n-hexane, toluene, dimethylbenzene, trimethylbenzene, benzene, chlorobenzene, petroleum ether, tetrahydrochysene furan
Mutter, one or more in 2- methyltetrahydrofurans, pentane and normal heptane.The volume mass ratio of organic solvent and compounds X V
Preferably 1ml/g ~ 100ml/g, more preferably 3ml, g ~ 20ml/g.Described alkali is preferably diisopropylethylamine, 1,8-
One or more in 11 carbon -7- alkene of diazabicylo [5.4.0], triethylamine and pyridine.Described alkali is with compounds X V's
Mol ratio can be 0.5 ~ 100, more preferably 1 ~ 50.Described dichloroacetyl chloride can be 0.5 ~ 10 with the mol ratio of compounds X V,
More preferably 0.8 ~ 3.The time of described addition reaction can be by, till detecting that reaction is no longer carried out, generally 0.25 ~ 72 is little
When, more preferably 0.5 ~ 24 hour.The temperature of described addition reaction is preferably -50 ~ 100 DEG C, more preferably -30 ~ 30 DEG C.
In the present invention, above-claimed cpd XV can be prepared by following either method:
Under inert gas shielding, in organic solvent, by compound R2The alkali metal salt of X and cyclopentadiene(Such as cyclopentadiene
Sodium)Or the alkali salt of cyclopentadiene carries out nucleophilic substitution as follows, you can;
Wherein, X be F, Cl, Br, OTf orR2It is as defined above described.
Wherein, the method and condition of described nucleophilic substitution can be the conventional method and bar of this kind of reaction in this area
Part, following conditions specifically preferred according to the invention:Described organic solvent is preferably tetrahydrofuran, petroleum ether, 2- methyl tetrahydrochysene furans
Mutter, one or more in n-hexane, pentane and normal heptane.Solvent and compound R2The volume mass ratio of X is preferably
1ml/g ~ 100ml/g, more preferably 3ml/g ~ 20ml/g.The alkali metal salt of described cyclopentadiene(Such as sodium cyclopentadiene)Or ring
The alkali salt and compound R of pentadiene2The mol ratio of X is preferably 0.5 ~ 10, more preferably 0.8 ~ 3.Described nucleophilic
The time of substitution reaction can be by, till detecting that reaction is no longer carried out, generally 0.25 ~ 72 hour, more preferably 0.5 ~ 24 is little
When.The temperature of described nucleophilic substitution is preferably -78 ~ 50 DEG C, more preferably -60 ~ 30 DEG C.
Without prejudice to the field on the basis of common sense, above-mentioned each optimum condition, can be combined, and obtain final product the present invention each preferably
Example.
Agents useful for same of the present invention and raw material are commercially available.
The present invention positive effect be:The preparation method raw material of the present invention is cheap and easy to get, and reaction condition is gentle, secondary
Reaction less, high income, environmental pollution it is little, intermediate is easy to purifies and separates, is suitable to industrialized production.
Specific embodiment
The present invention is further illustrated below by the mode of embodiment, but does not therefore limit the present invention to described reality
Among applying a scope.The experimental technique of unreceipted actual conditions in the following example, conventionally and condition, or according to business
Product specification is selected.
Example 1
Example 1-a
Ra=Me
In dichloromethane (1000ml) solution of as above initial compounds (50.0g, 164mmol), ice-water bath keeps 0 ~ 5
Degree Celsius, it is slowly added to diisobutyl aluminium hydride(2M toluene solutions, 180mL).Reaction is dropped after being kept for 4 hours at 0 ~ 5 degree Celsius
Temperature arrives -20 degrees Celsius, and is slowly added to methyl alcohol(50ml).The mixed liquor for obtaining adds distilled water after being evaporated organic solvent
2000ml.The suspension for obtaining is filtered through diatomite after being heated to 80 degrees Celsius, and it is Celsius that the filtrate for obtaining is slow cooling to 0
Degree.The crystalline powdery solid for obtaining is collected by filtration(39.7g, yield 82%), as required target product.
1H NMR(400MHz,DMSO-d6):δ10.57(br s,1H)7.69(s,1H)6.41(br s,2H)5.36(m,
1H)5.12(m,1H)4.89(s,1H)4.83(m,1H)4.58(m,1H)4.22(m,1H)3.55(m,2H)2.52(m,1H)2.21
(m,1H)2.04(m,1H)
13C NMR(100MHz,DMSO-d6):δ156.8,153.4,151.4,151.2,135.9,116.2,109.2,
70.3,62.9,55.0,54.0,39.2
ESI-MS:278.1[M+H]+
1 embodiment 1-b of table is to embodiment 1-g(In addition to table conditional, other conditions are with example 1-a)
Example 2
Example 2-a
Ra=Me,
In the water of the initial compounds as shown in above formula (65.0g, 173mmol)(1300mL)Saleratus is added in solution
(51.9g,519mmol), potassium fluoride(20g,345mmol).The mixed liquor for obtaining is slowly added to 30% hydrogen peroxide under 70 degrees Celsius
(110g,865mmol).Mixed liquor after completion of dropping is incubated under 70 degrees Celsius and adds acetic acid after stirring 3 hours
(115mL), and continue 70 degrees Celsius of insulation and stir 30 minutes.Mixed liquor is slow cooling to 5 degrees Celsius Jing after diatomite filtration.
The powder crystal for obtaining is collected by filtration to be scattered in 1000mL distilled water again after 5 degrees Celsius are distilled water washing, heats
It is allowed to be completely dissolved to 95 degrees Celsius.The clear liquid for obtaining is slow cooling to 5 degrees Celsius.The powder crystal for obtaining is collected by filtration simultaneously
It is dried and is required target compound(48.0g, yield 91%).
1H-NMR(400MHz,CD3OD)δ7.80(s,1H),5.44-5.39(m,1H),5.14(s,1H),4.70(s,1H),
4.30-4.28(m,1H),3.67(s,3H),2.69(s,1H),2.31-2.24(m,1H),2.14-2.08(m,1H);
13C-NMR(400MHz,CD3OD)δ170.0,159.8,155.6,153.8,152.2,140.0,117.7,112.0,
73.8,57.4,53.6,52.3,41.3
ESI-MS:306.1[M+H]+
Conventional method of the method that reaction can be used for Tamao-Fleming oxidation reactions, bibliography
(Fleming,I;Barbero,A;Walter,D;Chem Rev,1997,97,2063-2192).
2 embodiment 2-b of table is to embodiment 2-l(In addition to table conditional, other conditions are with example 2-a)
Example 3
Example 3-a
RaFor methyl.
In the dichloromethane of as above initial compounds (105.0g, 241mmol)(1050mL)Methanesulfonic acid is added in solution
(10.5ml).The brown liquid for obtaining is slowly dropped in the aqueous solution of potassium hydroxide after stirring 2 hours under 25 degrees Celsius(2M,
2L).The mixed liquor for obtaining adds acetic acid to pH=6 ~ 7 after being evaporated organic solvent.The solid dry as institute for obtaining is collected by filtration
The target compound for needing(77.7g, yield 86%).
1H-NMR(400MHz,CD3OD)δ7.80(s,1H),5.30(s,1H),5.02(s,1H),4.34-4.26(m,1H),
3.67(s,3H),3.08(d,1H),2.84(m,1H),2.39-3.37(m,1H),2.17-2.13(m,1H),1.85-1.45(m,
4H),1.25-1.05(m,2H);
13C-NMR(400MHz,CD3OD)δ170.0,156.5,155.2,153.9,153.1,117.4,112.1,59.7,
52.3,45.8,39.4,28.3,22.4,18.7,8.4;
ESI-MS:376.1[M+H]+
3 embodiment 3-b of table is to embodiment 3-r(In addition to table conditional, other conditions are with example 3-a)
Example 4
Example 4-a
RaFor methyl.
In the tetrahydrofuran of as above initial compounds (250.0g, 312mmol)(1000mL)Hydrochloric acid is added in solution(1M,
1500mL).After the brown liquid for obtaining is stirred 12 hours under 65 degrees Celsius, 25 degrees Celsius are cooled to, tetrahydrochysene furan is distilled off
Mutter.The clear liquid for obtaining is extracted through t-butyl methyl ether(200mL X2).The water for obtaining mutually is slowly dropped into the aqueous solution of potassium hydroxide
(2M)To pH=6 ~ 7.The solid for obtaining the target compound being dried needed for being is collected by filtration(129g, yield 95%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.80(s,1H),7.46(t,1H),7.38(d,1H),7.18
(t,1H),5.30(s,1H),5.02(s,1H),4.34-4.26(m,1H),3.67(s,3H),3.08(d,1H),2.84(m,
1H),2.39-2.37(m,1H),2.17-2.13(m,1H),1.85-1.55(m,4H),1.25-1.05(m,2H);
13C-NMR(400MHz,CD3OD)δ170.0,157.9,156.5,155.2,153.9,153.1,149.4,140.1,
133.8,128.2,122.8,117.4,112.1,59.7,52.3,47.8,32.0,24.5,19.3,7.6;;
ESI-MS:437.2[M+H]+
4 embodiment 4-b of table is to embodiment 4-r(In addition to table conditional, other conditions are with example 4-a)
Example 5
Example 5-a
RaFor methyl.
Nysted reagents under argon gas protection atmosphere(1200mL, 2M, tetrahydrofuran solution)Four are added under 0 ~ 5 degree Celsius
Titanium chloride(240ml, 1M, dichloromethane solution).The brownish red troubled liquor for obtaining is lowered the temperature after stirring 2 hours under 25 degrees Celsius
To 0 degree Celsius, and it is slowly added to compound shown in above formula(192g,240mmol).The mixture for obtaining is little in 0 degree Celsius of stirring 6
When after be slowly added into the saturated solution of sodium bicarbonate that is stirred vigorously under nitrogen atmosphere protection(2000mL)In.The mixture for obtaining
As a child filtered through diatomite in 25 degrees Celsius of stirrings 1, filter cake is through dichloromethane(1000mL)Stir and wash.The water phase of merging and
It is organic to be added to salt(600g)Layering is filtered after saturation.Detached organic phase is evaporated organic solvent after magnesium sulfate drying
Obtain target product crude product(163g, yield 85%)
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),8.1(s,1H),7.60-7.10(m,20H),6.70(d,2H),
5.30(s,1H),5.24(s,2H),5.02(s,1H),4.34-4.26(m,1H),3.75(s,3H),3.67(s,3H),3.08
(d,1H),2.84(m,1H),2.39-2.37(m,1H),2.17-2.13(m,1H),1.85-1.45(m,4H),1.25-1.05
(m,2H);
13C-NMR(400MHz,CD3OD)δ170.0,159.9,157.9,156.5,155.2,153.9,153.1,149.4,
148.0,140.2,140.1,137.1,133.8,132.5,130.9,130.5,129.8,129.7,129.3,129.1,
128.2,122.8,117.4,115.8,112.1,74.9.73.0,71.1,57.6,52.3,47.7,31.5,24.5,19.2,
7.6
ESI-MS:799.3[M+H]+
5 embodiment 5b-5r of table(In addition to table conditional, other conditions are with example 5-a)
Example 6
Example 6-a
RaFor methyl.
In the N,N-dimethylformamide of the initial compounds (230g, 436mmol) shown in above formula(1050mL)Middle addition
DMAP(80g, 654mmol)With 4- methoxyphenyls-diphenyl methyl chloride(269g, 872mmol).What is obtained is anti-
Liquid is answered to be slowly added to sodium hydrate aqueous solution after stirring 36 hours under 25 degrees Celsius(0.5M,1000mL).The turbid solution for obtaining
T-butyl methyl ether extraction is added in body(600mL X3).The t-butyl methyl ether of merging is concentrated to after sodium sulphate drying
750mL, and n-hexane is slowly added under 45 degrees Celsius(1200mL)And cool to -20 degrees Celsius.The pin for obtaining is collected by filtration
Shape solid the target compound intermediate being dried needed for being(251g, yield 72%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),8.1(s,1H),7.60-7.10(m,20H),6.70(d,2H),
5.24(s,2H)4.34-4.26(m,1H),3.75(s,3H),3.67(s,3H),2.98(d,1H),2.84(m,1H),2.79-
2.77(m,1H),2.67-2.63(m,1H),1.85-1.45(m,4H),1.25-1.05(m,2H);
13C-NMR(400MHz,CD3OD)δ208.2,170.0,167.9,159.9,156.5,153.9,153.1,149.4,
148.0,140.2,139.0,137.1,133.8,132.5,130.9,130.5,129.8,129.7,129.3,129.1,
128.2,122.8,117.4,115.8,78.5,74.9.73.0,57.6,55.4,51.9,31.9,20.8,15.8,3.3;
ESI-MS:801.3[M+H]+
6 embodiment 6-b to 6-r of table(In addition to table conditional, other conditions are with example 6-a)
Example 7
Example 7-a
RaFor methyl.
In the dichloromethane of the initial compounds (270g, 482mmol) shown in above formula(1080mL)Saturation is added in solution
Sodium bicarbonate solution(3240mL)And cool to 0 degree Celsius.It is slowly added to sodium metaperiodate solid(114g, 530mmol).Obtain
Reactant liquor stirred 2 as a child under 0 degree Celsius, was slowly added to hypo solution(1M,100mL).The mixed liquor for obtaining is quiet
After putting point liquid, water is extracted through dichloromethane(600mL X2).Merge all of organic phase after sodium sulphate drying, concentrate
1200mL n-hexanes are slowly added to 600mL and under 35 degrees Celsius.Mixed liquor is collected by filtration after being slow cooling to -10 degrees Celsius
The powder for obtaining dry, as required target compound intermediate(234g, yield 92%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.80(s,1H),7.60-7.15(m,8H),5.24(s,2H)
4.34-4.26 (m, 1H), 3.67 (s, 3H), 2.98 (d, 1H), 2.84 (s,1H), 2.79-2.77 (m, 1H), 2.67-2.63 (m,
1H),1.85-1.45(m,4H),1.25-1.05(m,2H);
13C-NMR(400MHz,CD3OD)δ208.2,170.0,167.9,161.1,156.5,153.1,149.4,139.0,
137.1,133.8,129.8,129.7,129.3,128.2,122.8,117.4,78.5,74.9.55.4,51.9,31.9,
20.8,15.8,3.3;
ESI-MS:529.2[M+H]+
7 embodiment 7-b to 7-r of table(In addition to table conditional, other conditions are with example 7-a)
Example 8
Example 8-a
RaFor methyl.
In the N,N-dimethylformamide of the initial compounds (250g, 784mmol) shown in above formula(1000mL)Middle addition
O-6- benzyl guanines(227g, 941mmol)And lithium hydroxide(1.88g,78.4mmol).The suspended liquid for obtaining is Celsius 95
After the lower stirring of degree 12 hours, Jing vacuum distillations are concentrated to 300mL.It is molten that the concentrate is slowly dropped to 1000mL sodium acid carbonate saturations
In liquid.The solid of generation is collected by filtration and be dried after water washing with being distilled.The solid is dissolved in ethyl acetate(300mL)Afterwards through
300g silica gel is filtered, and silica gel is through the further drip washing of 1200mL ethyl acetate.Merge all ethyl acetate phases for leaching and be evaporated
Organic solvent.The faint yellow solid for obtaining is required target compound intermediate(364g, yield 83%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.80(s,1H),7.60-7.15(m,8H),5.64(s,2H),
3.84-3.72(m,1H),3.74(d,1H),3.49(d,1H),3.67(s,3H),2.48(d,1H),2.24-2.16(m,1H),
1.89-1.45(m,6H),1.25-1.05(m,2H);
13C-NMR(400MHz,CD3OD)δ174.6,167.9,161.1,156.5,153.1,149.4,139.0,137.1,
133.8,129.8,129.7,129.3,128.2,122.8,117.4,83.8,74.9,66.1,63.4,52.2,40.3,21.9,
21.6,16.4,4.1;
ESI-MS:561.2[M+H]+
8 embodiment 8-b to 8-r of table(In addition to table conditional, other conditions are with example 8-a)
Example 9
Example 9-a
RaFor methyl.
The reaction uses conventional Sharpless chiral epoxy reaction process Review literatures:(Pfenninger,
A.Synthesis1986,89)
Tetraisopropoxy titanium is added in 2400mL dichloromethane(96mL, 335mmol)And it is cooled to subzero 30 degrees Celsius.
The initiation material as shown in above formula is added inside the solution(507g,1.68mol)With(2S,3S)- tartaric acid diisopropyl ester(94g,
402mmol).The mixed liquor for obtaining is slowly added to anhydrous tert-Butanol peroxide after stirring 1 hour under subzero 30 degrees Celsius(2.5M,
Toluene solution, 800mL).Reaction temperature is kept thiosulfuric acid to be slowly added in reactant liquor at subzero 20 ~ 30 degrees Celsius after 3 hours
Sodium(2M, 500mL).After completion of dropping, reactant liquor is slowly warmed up to 25 degrees Celsius and filters through diatomite.The filtrate Jing for obtaining
After crossing stratification, isolated water is extracted through dichloromethane(1000mL X2)After merge all of dichloromethane.Close
And organic phase further across saturated ammonium chloride(500mL)And saturated aqueous common salt(200mL)Jing sodium peroxydisulfates after substep washing
It is dried.It is evaporated the pale yellow oily liquid that organic solvent obtains and is required target compound intermediate(488g, yield
91%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.60-7.35(m,3H),3.74(d,1H),3.49(d,1H),
3.67(s,3H),2.78(d,1H),2.51(d,1H),2.24-2.16(m,1H),1.89-1.45(m,6H),1.25-1.05(m,
2H);
13C-NMR(400MHz,CD3OD)δ174.6,167.9,149.4,133.8,128.2,122.8,77.6,64.3,
63.8,52.2,40.3,21.9,21.6,16.4,4.1;
ESI-MS:320.1[M+H]+
9 embodiment 9-b to 9-r of table(In addition to table conditional, other conditions are with example 9-a)
Example 10
Raw material in the embodiment series is the equal amount of mixture of following two structures:
Example 10-a
RaFor methyl.
In the initiation material as shown in above formula(520g, 1.80mol)2600 milliliters of isopropanols are dissolved in, and add (1R, 2R) -2-
Amino -1- (4- nitrobenzophenones) propane -1,3- glycol(cas:716-61-0)(212g, 1.0mol).The mixed solution for obtaining exists
25 degrees Celsius are slow cooling to after stirring 2 hours under 70 degrees Celsius.1200 millis are dissolved in after the solid drying for obtaining is collected by filtration
Rise methyl alcohol and be slowly added to the concentrated sulfuric acid(98%, 120mL).The mixed liquor for obtaining is stirred at room temperature 12 and was as a child slowly added to hydrogen
Aqueous solution of sodium oxide(3M,3000mL).The mixed liquor for obtaining is through n-hexane extraction(2000mL X2).Organic phase is obtained by extraction
Organic solvent is evaporated after dried over sodium sulfate, the pale yellow oily liquid for obtaining is required target compound intermediate
(223g, yield 82%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.60-7.35(m,3H),5.59(s,1H),4.20(s,2H),
3.67(s,3H),3.18(d,1H),2.64(m,1H),2.49-2.47(m,1H),2.27-2.23(m,1H),1.85-1.45(m,
4H),1.05-1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ174.6,167.9,149.4,133.8,131.0,128.2,122.8,123.5,
66.3,52.3,44.4,29.0,21.6,17.3,16.5;
ESI-MS:304.1[M+H]+
10 embodiment 10-b to 10-r of table(In addition to table conditional, other conditions are with example 10-a)
Example 11
In the embodiment series, raw material is the equal amount of mixture of following two structures:
Product is the equal amount of mixture of following two structures:
Example 11-a
In the initiation material as shown in above formula(505g, 1.76mol)It is dissolved in 2600 milliliters of ethanol and adds hydroboration in batches
Sodium(66.9g, 1.76mol).The mixture for obtaining is stirred at room temperature 3 and as a child cooled to 0 degree Celsius, and adds 500 milliliters
Saturated ammonium chloride solution.Mixed liquor adds ethyl acetate extraction after being evaporated organic solvent(2000mL X3).Organic phase Jing of merging
Supersaturation brine It(1000mL)It is dried through sodium sulphate again afterwards, is evaporated needed for the faint yellow solid that organic phase obtains is
Target compound intermediate(482g, yield 95%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.60-7.35(m,3H),5.59(s,1H),4.20(s,2H),
3.28(d,1H),2.49-2.47(m,1H),2.34(s,1H),2.27-2.23(m,2H),1.85-1.45(m,4H),1.05-
1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ182.7,167.9,149.4,133.8,131.0,128.2,123.5,122.8,
66.3,46.9,29.0,21.6,17.0,16.5;
ESI-MS:290.1[M+H]+
11 embodiment 11-b to 11-r of table(In addition to table conditional, other conditions are with example 11-a)
Example 12
In the embodiment series, raw material is the equal amount of mixture of following two structures:
Product is the equal amount of mixture of following two structures:
Example 12-a
In the initiation material as shown in above formula(723g, 2.52mol)Be dissolved in 2600 milliliters of ethanol carbonic acid is added under 0 degree Celsius
Sodium(534g, 5.04mol).The mixture for obtaining is filtered after being stirred at room temperature 3 hours.The filtrate for obtaining adds watery hydrochloric acid(3M,
850mL), after mixed liquor is evaporated organic solvent, addition ethyl acetate is beaten(2000mL X3).The organic phase of merging is eaten through saturation
Salt water washing(1000mL)It is dried through sodium sulphate again afterwards, is evaporated the faint yellow solid that organic phase obtains and is required targeted
Compound intermediate(706g, yield 98%).
1H-NMR(400MHz,CD3OD)δ9.68(s.1H),8.68(d,1H),7.60-7.35(m,3H),6.55(s,1H),
3.28(d,1H),2.49-2.47(m,1H),2.27-2.23(m,2H),1.85-1.45(m,4H),1.05-1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ192.9,182.7,167.9,156.7,149.4,133.8,129.2,128.2,
122.8,43.2,28.5,21.6,16.5,16.4;
ESI-MS:288.1[M+H]+
12 embodiment 12-b to 12-r of table(In addition to table conditional, other conditions are with example 12-a)
Example 13
In the series embodiment, product is the equal amount of mixture of following two compounds.
Example 13-a
In the initiation material as shown in above formula(491g, 1.52mol)The tert-butyl alcohol(982g)And water(1960g)In mixed solution
Triethylamine 706g is instilled under 25 degrees Celsius.Drip off rear reactant liquor and be warming up to 85 degree and allow which to flow back, heating was down to 0 after about 60 minutes.
It is evaporated organic solvent mixed liquor to be kept for 0 ~ 5 degree Celsius and be slowly added to concentrated hydrochloric acid(37%)Adjust pH ~ 6.Mixed liquor is through acetic acid second
Ester is extracted(2600mL X3).The organic phase of merging is dried through saturated common salt water washing, with sodium sulphate and is evaporated organic solvent and obtains
The buff oily liquids for arriving is required target compound intermediate(327g, yield 75%).
1H-NMR(400MHz,CD3OD)δ9.72(s.1H),8.68(d,1H),7.60-7.35(m,3H),6.00(s,1H),
5.59(s,1H),3.46(d,1H),3.08(m,1H),2.60(d,1H),1.85-1.45(m,4H),1.05-1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ201.5,183.1,167.9,149.4,134.2,133.8,129.1,128.2,
122.8,57.5,34.3,21.7,19.1,16.5;
ESI-MS:288.1[M+H]+
13 embodiment 13-b to 13-r of table(In addition to table conditional, other conditions are with example 13-a)
Example 14
Example 14-a
It is dissolved in 1800ml n-hexanes in the initiation material 254g (1.19mol) as shown in above formula, is cooled to 0 degree Celsius,
Add dichloroacetyl chloride (390.5g, 2.65mol), triethylamine (535g, 5.30mol) is added dropwise under maintaining 5 ~ 10 degrees Celsius, is dripped off
Mixed liquor afterwards is stirred 14 hours under 25 degrees Celsius.Water is added in reaction mixture(1500ml).The water that standing separation is obtained
N-hexane is used mutually(500ml X3) extraction.The organic phase saturated common salt water washing of merging and it is dried over sodium sulfate after be evaporated it is organic
Solvent obtains buff oily liquids and is required target compound intermediate(378g, yield 98%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.60-7.35(m,3H),6.00(s,1H),5.59(s,1H),
4.08(d,1H),3.68-3.57(m,1H),2.74(s,1H),1.85-1.45(m,4H),1.05-1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ183.1,167.9,149.4,138.0,133.8,129.2,128.2,122.8,
88.3,70.1,34.0,21.7,19.1,16.5;
ESI-MS:324.1[M+H]+
14 embodiment 14-b to 14-r of table(In addition to table conditional, other conditions are with example 14-a)
Example 15
Example 15-a
Sodium cyclopentadiene(165g, 1.87mol)It is dissolved in 1650ml tetrahydrofurans, is cooled under nitrogen protection subzero
50 degrees Celsius, it is added dropwise in the initiation material as shown in above formula(271g, 1.48mol), it is little that temperature control reacts about 3 at subzero 45 degrees Celsius
When.1000ml water quenchings are added to go out reaction after the completion of reaction.Evaporate remaining mixed liquor n-hexane after tetrahydrofuran(1500ml
X3)Extraction.The organic phase of merging uses 0.5M hydrochloric acid successively(0.5M,500mL)With saturated common salt water washing, organic phase with sodium sulfate
It is dried, filters, is spin-dried for organic solvent and obtains the target compound intermediate needed for oily bronzing liquid is(299g, yield
95%).
1H-NMR(400MHz,CD3OD)δ8.68(d,1H),7.60-7.35(m,3H),6.62-6.52(m,4H),3.61
(s,1H),1.85-1.45(m,4H),1.05-1.25(m,2H);
13C-NMR(400MHz,CD3OD)δ167.9,149.4,133.8,133.0,132.0,128.2,122.8,21.7,
19.1,16.5;
ESI-MS:214.1[M+H]+
15 embodiment 15-b to 15-r of table(In addition to table conditional, other conditions are with example 15-a)
Example 16R2- X synthesizes
R2The synthesis of-Cl has description in detail in the document in documents below and cited in them:
Russian Journal of General Chemistry2006,76,1261
Chemische Berichte1915,48,1238
Journal of Organometallic Chemistry1975,86,197
Journal of the American Chemical Society1946,68,485
Journal of the American Chemical Society2010,132,8270
Its general principle can be represented by formula illustrated below:
Wherein R-21 is corresponding aromatic ring yl lithium compound.Wherein W1, W2 are respectively independent-MgBr or-MgCl
Example 16-a
Synthetic method one
Step one:In 2- chloropyridines(1.15Kg, 10.2mol)Tetrahydrofuran(4600mL)Subzero 40 are kept to arrive in solution
Subzero 50 degrees Celsius of dropwise additions butyl lithium(2.5M hexane solutions, 4200mL).Reactant liquor after completion of dropping is slowly warmed up to 25
Degree Celsius and at such a temperature stir 2 hours.The brownish red reactant liquor for obtaining adds four chlorinations for being pre-chilled to subzero 50 degrees Celsius
Silicon(1.7Kg,10mol)Tetrahydrofuran(6800mL)In solution.Control rate of addition keeps system subzero 40 to subzero 50 to take the photograph
Family name's degree.The mixed liquor obtained after completion of dropping be slowly warmed up to 25 degrees Celsius and at such a temperature stir 12 hours after in blanket of nitrogen
Enclose to push and filter the solid for generating.Filtrate be pre-chilled to subzero 50 degrees Celsius it is standby.
Step 2:1,3- dibromopropanes(2.2Kg,10.9mol)It is slowly added into suspension 264g magnesium chips in stirring(11mol)
Tetrahydrofuran(17.6L)In.Control rate of addition keeps reaction temperature at subzero 40 ~ 50 degrees Celsius.It is incubated after completion of dropping
Subzero 50 degrees Celsius are pre-chilled in subzero 40 ~ 50 degrees Celsius mixed liquors obtained after 2 hours, and add what is prepared by 2- chloropyridines
Reaction mixture.Control rate of addition keeps reaction temperature at subzero 40 ~ 50 degrees Celsius.Slowly it is warmed up to 60 to take the photograph after completion of dropping
Family name's degree simultaneously stirs 3 hours.Vacuum distillation concentration of reaction solution adds n-hexane to after 20 liters(20L).It is filtered to remove the solid of generation.
Distillation under pressure after filtrate concentration obtains colourless liquid and is required target compound intermediate(1.16Kg,62%).
Synthetic method two
Example 16-b
Step one:1,3- dibromopropanes(2.2Kg,10.9mol)It is slowly added into suspension 264g magnesium chips in stirring(11mol)
Tetrahydrofuran(17.6L)In.Control rate of addition keeps reaction temperature at subzero 40 ~ 50 degrees Celsius.It is incubated after completion of dropping
Subzero 50 degrees Celsius are pre-chilled in subzero 40 ~ 50 degrees Celsius mixed liquors obtained after 2 hours.Four chlorinations are added dropwise in the reactant liquor
Silicon(1.7Kg,10mol).Control rate of addition keeps reaction temperature at subzero 40 ~ 50 degrees Celsius.Slowly heat up after completion of dropping
Lower the temperature to 60 degrees Celsius and after stirring 3 hours and be pre-chilled to subzero 50 degrees Celsius.
Step 2:In 2- chloropyridines(1.15Kg, 10.2mol)Tetrahydrofuran(4600mL)Subzero 40 are kept to arrive in solution
Subzero 50 degrees Celsius of dropwise additions butyl lithium(2.5M hexane solutions, 4200mL).Reactant liquor after completion of dropping is slowly warmed up to 25
Degree Celsius and at such a temperature stir 2 hours.The brownish red reactant liquor for obtaining is pre-chilled to subzero 50 degrees Celsius, and is slowly added into
Step one is prepared in reactant liquor.Control rate of addition keeps reaction temperature at subzero 40 ~ 50 degrees Celsius.Obtain after completion of dropping
Mixed liquor be slowly warmed up to 25 degrees Celsius and at such a temperature stir 12 hours after, pressure distillation and concentration reactant liquor add to after 20 liters
N-hexane(20L).It is filtered to remove the solid of generation.Distillation under pressure after filtrate concentration obtains colourless liquid and is required targeted
Compound intermediate(1.53Kg,82%).
1H-NMR(400MHz,CDCl3)δ8.68(d,1H),7.60-7.35(m,3H),1.85-1.45(m,4H),1.05-
1.25(m,2H);
13C-NMR(400MHz,CDCl3)167.9,149.4,133.8,128.2,122.8,17.6,12.5
16 embodiment 16-b to 16-r of table
Claims (7)
1. a kind of preparation method of the intermediate of the Entecavir as shown in formula IV or IV ', it is characterised in that comprise the steps of:
In solvent, in the presence of Bronsted acid, compound V is carried out as follows sloughing the anti-of amino protecting group and hydroxyl protecting group
Should, you can;
Wherein, RaFor C1~C4Straight chained alkyl;RbRepresent one or more on phenyl ring selected from halogen atom, methoxyl group or methyl
Substituent or H;RcFor methyl;R2The arbitrary substituent being as follows:
Wherein, R21For unsubstituted C6Aryl, or be following arbitrary substituent:
2. preparation method as claimed in claim 1, it is characterised in that:Work as RaFor C1~C4Straight chained alkyl when, described C1~
C4Straight chained alkyl be methyl.
3. preparation method as claimed in claim 1, it is characterised in that:Described solvent is organic solvent, water or theirs is mixed
Compound, wherein described organic solvent be dichloromethane, methyl alcohol, ethanol, isopropanol, the tert-butyl alcohol, tetrahydrofuran, acetonitrile, DMF and
One or more in dimethyl sulfoxide (DMSO);Described Bronsted acid is in hydrochloric acid, sulfuric acid, nitric acid, trifluoroacetic acid and methanesulfonic acid
Plant or various;Bronsted acid is 0.1~100 with the mol ratio of compound V;The temperature of described reaction is 0~100 DEG C.
4. preparation method as claimed in claim 3, it is characterised in that:Bronsted acid is 1~20 with the mol ratio of compound V;Institute
The temperature of the reaction stated is 20~80 DEG C.
5. preparation method as claimed in claim 1, it is characterised in that:The compound V is prepared by following methods, then is prepared
Compound IV:
Under inert gas shielding, in organic solvent, in the presence of titanium tetrabromide or titanium tetrachloride, by compound VI and Na Site
Reagent carries out methylenation, you can;
Wherein, Ra、Rb、RcAnd R2Definition with described in claim 1.
6. preparation method as claimed in claim 5, it is characterised in that:In described methylenation:Described is organic molten
Agent is one or more in tetrahydrofuran, 2- methyltetrahydrofurans, ether and t-butyl methyl ether;Described Nysted Reagent with
The mol ratio of compound VI is 0.5~10;The mol ratio of described titanium tetrabromide or titanium tetrachloride and compound VI is 0.1~
10;The temperature of described methylenation is -78~50 DEG C.
7. the midbody compound of the Entecavir as shown in Formula V or VI;Or the intermediate of the Entecavir as shown in formula IV
Compound or its dynamic isomer IV ':
Wherein, Ra、Rb、RcAnd R2Definition with described in claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310062883.4A CN104017016B (en) | 2013-02-28 | 2013-02-28 | The preparation method of the intermediate of one class Entecavir, and intermediate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310062883.4A CN104017016B (en) | 2013-02-28 | 2013-02-28 | The preparation method of the intermediate of one class Entecavir, and intermediate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104017016A CN104017016A (en) | 2014-09-03 |
| CN104017016B true CN104017016B (en) | 2017-04-05 |
Family
ID=51434060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310062883.4A Active CN104017016B (en) | 2013-02-28 | 2013-02-28 | The preparation method of the intermediate of one class Entecavir, and intermediate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104017016B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865848A (en) * | 1969-10-13 | 1975-02-11 | Searle & Co | Methylenation reagent |
| CN101781301A (en) * | 2010-01-15 | 2010-07-21 | 复旦大学 | Method for preparing entecavir |
| CN101838207A (en) * | 2006-08-24 | 2010-09-22 | 江苏正大天晴药业股份有限公司 | Intermediates of Entecavir and synthesis method thereof |
| CN101899063A (en) * | 2002-12-11 | 2010-12-01 | 布里斯托尔-迈尔斯斯奎布公司 | Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
-
2013
- 2013-02-28 CN CN201310062883.4A patent/CN104017016B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865848A (en) * | 1969-10-13 | 1975-02-11 | Searle & Co | Methylenation reagent |
| CN101899063A (en) * | 2002-12-11 | 2010-12-01 | 布里斯托尔-迈尔斯斯奎布公司 | Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
| CN101838207A (en) * | 2006-08-24 | 2010-09-22 | 江苏正大天晴药业股份有限公司 | Intermediates of Entecavir and synthesis method thereof |
| CN101781301A (en) * | 2010-01-15 | 2010-07-21 | 复旦大学 | Method for preparing entecavir |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104017016A (en) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2647316C (en) | Process for preparation of hiv protease inhibitors | |
| JP2013047277A5 (en) | ||
| CN103304375B (en) | Synthesis intermediate of Entecavir and preparation method thereof | |
| CN105061431B (en) | 6‑N‑(2‑(Methyl mercapto)Ethyl)‑2‑((3,3,3 trifluoro propyls)It is thio)9H purine and its preparation method and application | |
| CN102630226A (en) | Entecavir synthesis method and intermediate compound thereof | |
| CN102153601A (en) | Method for preparing gemcitabine hydrochloride and intermediate thereof with high selectivity | |
| CN104017016B (en) | The preparation method of the intermediate of one class Entecavir, and intermediate | |
| CN104017015B (en) | The preparation method of the intermediate of one class Entecavir, and intermediate | |
| CN105153257B (en) | The preparation method of Suo Feibuwei | |
| TWI445711B (en) | Improved method for preparation of adefovir dipivoxil | |
| CN104017014A (en) | Entecavir intermediates and preparation method thereof | |
| CN104017013A (en) | Entecavir intermediates and preparation method thereof | |
| CN104177394B (en) | Entecavir midbodies and preparation method thereof | |
| CN101805339B (en) | Entecavir compound preparation method | |
| CN104016984A (en) | Entecavir, intermediates thereof and preparation methods of Entecavir and intermediates thereof | |
| CN104017012A (en) | Entecavir intermediates and preparation method thereof | |
| CN104177396A (en) | Entecavir intermediates and preparation methods thereof | |
| CN104177398B (en) | Entecavir midbodies and preparation method thereof | |
| CN104177397B (en) | Entecavir midbodies and preparation method thereof | |
| CN107513048A (en) | A kind of synthetic method of deuterated Vortioxetine hydrobromate | |
| CN115557967B (en) | 4-Nitrophthaloyl aza crown ether compound, preparation method and application | |
| CN105330690A (en) | Synthetic method of drug intermediate aryl ketone phosphate ester compound | |
| CN104926847B (en) | A kind of synthesis boron aminated compounds technique and products application | |
| CN104177360A (en) | Preparation method of entecavir, entecavir intermediate and preparation method of entecavir intermediate | |
| CN106496208A (en) | The preparation method of emtricitabine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 314200 room 410, building 1, No. 988, Xinxing Second Road, Pinghu Economic Development Zone, Jiaxing City, Zhejiang Province Patentee after: Zhejiang Xingyue Pharmaceutical Technology Co.,Ltd. Address before: 314200 room 410, building 1, No. 988, Xinxing Second Road, Pinghu Economic Development Zone, Jiaxing City, Zhejiang Province Patentee before: HSING PHARMACEUTICALS Co.,Ltd. |